Fina Biotech is committed to the development of innovative products that contribute to improving quality of life in the form of new tools for the monitoring, diagnosis, prognosis and treatment of significant diseases

Fina Biotech has made a great financial and research effort to develop these new products to a point of excellence that give us the certainty that our products will have no competence in a potential market.

Fina Biotech continues with its investigations in oncology, cardiology and stem cell therapy, searching significant relationships with the new growing subject of personalized medicine, since they have being seen with interest by a large number of companies of the diagnosis, pharmaceutical and biotech field.